A

Ascendis Pharma

Biopharmaceutical company developing long-acting prodrugs

Associate Director - GCP Quality

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeHellerup, DenmarkNo salary listed

About the Job

Requirements

  • Hold a relevant academic degree; a master's degree in life sciences is preferred.
  • Have at least 8 years of experience in GCP quality within the pharmaceutical industry.
  • Be proficient in written and spoken English at a professional level.
  • Have demonstrated experience as a lead GCP auditor of clinical trial sites and service providers.
  • Have strong working knowledge of drug development, clinical operations, regulatory authorities, and/or quality assurance.
  • Hold a lead auditor certification.

Responsibilities

  • Plan, perform, and report internal, clinical trial site, and service provider GCP audits.
  • Review and analyze audit, inspection, deviation, and corrective and preventive action (CAPA) data to identify root causes, compliance trends, and areas of GCP exposure.
  • Review and approve quality intakes, serious breach reporting, deviations, and CAPAs.
  • Provide expert compliance and regulatory advice within GCP.
  • Author and maintain procedures owned by GCP Quality.
  • Monitor regulatory intelligence, assess its impact, and support implementation of new or updated GCP regulations.
  • Lead and support the planning, conduct, and follow-up of regulatory inspections.
  • Collaborate with subject matter experts to formulate responses to GCP-related inspection findings.
  • Drive quality development initiatives within the GCP area.
  • Provide expert consultation on complex GCP aspects to project teams and departments.
  • Perform the role of quality partner to assigned departments.

Desired Qualifications

  • A master's degree in life sciences is preferred.

About the Company

Ascendis Pharma

Biopharmaceutical company developing long-acting prodrugs

Ascendis Pharma uses its TransCon technology to create long-acting prodrugs for rare endocrine diseases, with expansions into oncology and ophthalmology. The platform temporarily attaches an unmodified drug to an inert carrier and releases the active drug in a predictable, sustained way after injection, reducing how often patients must dosing. It differentiates itself through a proprietary delivery system and a track record that includes marketed therapies like SKYTROFA for pediatric growth hormone deficiency and YORVIPATH for hypoparathyroidism, along with collaborations such as a Novo Nordisk deal. The company aims to improve patient outcomes by enabling easier, less frequent dosing while expanding its pipeline across rare endocrine diseases, cancer, and eye diseases.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Gentofte Municipality, Denmark
Founded
2007

Recently Posted Jobs

Explore more opportunities at Ascendis Pharma

See more jobs